An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer

An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer

Secretin-stimulated pancreatic juice (PJ), collected from the duodenum, presents a valuable biomarker source for the (earlier) detection of pancreatic cancer (PC). Here, we evaluate the feasibility and performance of shallow sequencing to detect copy number variations (CNVs) in cell-free DNA (cfDNA)...

Full description

Bibliographic Details
Main Authors:	Iris J. M. Levink, Malgorzata I. Srebniak, Walter G. De Valk, Monique M. van Veghel-Plandsoen, Anja Wagner, Djuna L. Cahen, Gwenny M. Fuhler, Marco J. Bruno
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	cfDNA copy number variant CNV liquid biopsy NIPT
Online Access:	https://www.mdpi.com/1422-0067/24/6/5097

Similar Items

What proportion of couples with a history of recurrent pregnancy loss and with a balanced rearrangement in one parent can potentially be identified through cell-free DNA genotyping?
by: Laura J. C. M. van Zutven, et al.
Published: (2023-09-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report
by: Nuria Balaguer, et al.
Published: (2021-01-01)

Role of Sonographic Second Trimester Soft Markers in the Era of Cell-Free DNA Screening Options: A Review
by: Cristina Taliento, et al.
Published: (2022-08-01)

Trophoblast retrieval from the cervical canal to predict abnormal pregnancy early in gestation: a pilot study
by: Xiaoke Yang, et al.
Published: (2023-03-01)

Case Report: Challenges of Non-Invasive Prenatal Testing (NIPT): A Case Report of Confined Placental Mosaicism and Clinical Considerations
by: Giulia Bonanni, et al.
Published: (2022-05-01)

Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
by: Wilson V. Chan, et al.
Published: (2018-01-01)

Fetal sex discordance
by: Álvaro López Soto, et al.
Published: (2020-09-01)

Pilot Screening of Cell-Free mtDNA in NIPT: Quality Control, Variant Calling, and Haplogroup Determination
by: Alisa Morshneva, et al.
Published: (2021-05-01)

Calculation of Fetal Fraction for Non-Invasive Prenatal Testing
by: Matthew Cserhati
Published: (2021-08-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

NIPT Technique Based on the Use of Long Chimeric DNA Reads
by: Vera Belova, et al.
Published: (2020-05-01)

Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction
by: Graziano Santoro, et al.
Published: (2021-11-01)

Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies
by: Elena E. Baranova, et al.
Published: (2022-08-01)

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
by: Ariana Huebner, et al.
Published: (2023-04-01)

Improved noninvasive fetal variant calling using standardized benchmarking approaches
by: Tom Rabinowitz, et al.
Published: (2021-01-01)

Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer
by: Iris J. M. Levink, et al.
Published: (2023-08-01)

Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA
by: Xunliang Tong, et al.
Published: (2022-06-01)

A case of placental trisomy 18 mosaicism causing a false negative NIPT result
by: Jiexia Yang, et al.
Published: (2017-10-01)

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
by: Erica Soster, et al.
Published: (2023-06-01)

Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
by: Kavish Kohabir, et al.
Published: (2021-04-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
by: José Manuel González de Aledo-Castillo, et al.
Published: (2021-07-01)

A new primer construction technique that effectively increases amplification of rare mutant templates in samples
by: Jr-Kai Huang, et al.
Published: (2019-08-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
by: Ellis L. Eikenboom, et al.
Published: (2023-09-01)

Performances of NIPT for copy number variations at different sequencing depths using the semiconductor sequencing platform
by: Jiexia Yang, et al.
Published: (2021-07-01)

Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory’s Retrospective Experience
by: Erica Soster, et al.
Published: (2023-10-01)

Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01)

Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy
by: Tian-Bao Yan, et al.
Published: (2021-12-01)

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic Cancer
by: Shengyue Li, et al.
Published: (2020-12-01)

Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
by: Yu Zhang, et al.
Published: (2024-03-01)

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
by: Javier Oliver, et al.
Published: (2023-06-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Improved library preparation protocols for amplicon sequencing-based noninvasive fetal genotyping for RHD-positive D antigen-negative alleles
by: Asuka Hori, et al.
Published: (2021-09-01)

Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology
by: Wanxia Gai, et al.
Published: (2021-03-01)

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
by: Marina Bortul, et al.
Published: (2023-05-01)